Update on peripheral ulcerative keratitis

References

• GalorAThorneJEScleritis and peripheral ulcerative keratitisRheum Dis Clin N Am200733835854
   PubMed Web of Science ®Google Scholar
• OdorcicSKeystoneECMaJJInfliximab for the treatment of refractory progressive sterile peripheral ulcerative keratitis associated with late corneal perforation: 3-year follow-upCornea200928899219092414
   PubMed Web of Science ®Google Scholar
• BartlyJMondinoBJInflammatory diseases of the peripheral corneaOphthalmology1988954634723050690
   PubMed Web of Science ®Google Scholar
• TauberJSainz de la MazaMHoang-XuanTFosterCSAn analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitisCornea1990966732297997
   PubMed Web of Science ®Google Scholar
• LadasJGMondinoBJSystemic disorders associated with peripheral corneal ulcerationCurr Opin Ophthalmol20001146847111141643
   PubMedGoogle Scholar
• ChungGPhlyctenular keratoconjunctivitis and marginal staphylococcal keratitisKrachmerJHMannisMJHollandEJCornea: Fundamentals, Diagnostic, Management3rd edSt Louis, MOElsevier2011
   Google Scholar
• AkpekEKThorneJEQaziFADoDVJabsDAEvaluation of patients with scleritis for systemic diseaseOphthalmology200411150150615019326
   PubMed Web of Science ®Google Scholar
• MessmerEMFosterCSVasculitic peripheral ulcerative keratitisSurv Ophthalmol19994337939610340557
   PubMed Web of Science ®Google Scholar
• FosterCSForstotSLWilsonLAMortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis: Effects of systemic immune suppressionOphthalmology198491125312636514289
   PubMed Web of Science ®Google Scholar
• DanaMRQianYHamrahPTwenty-five year panorama of corneal immunologyCornea20001962564311009315
   PubMed Web of Science ®Google Scholar
• ChowYCFosterCSMooren’s ulcerInt Ophthalmol Clin1996361138778056
   PubMedGoogle Scholar
• BrownSIWhat is Mooren’s ulcer?Trans Ophthalmol Soc U K197898390392382458
   PubMedGoogle Scholar
• AllansmithMRMcClellanBImmunoglobulins in the human corneaAm J Ophthalmol1975801231321155538
   PubMed Web of Science ®Google Scholar
• MondinoBJBradyKJDistribution of hemolytic complement activity in normal human donor corneaArch Ophthalmol198199143014437020664
   PubMedGoogle Scholar
• HoganMJAlvaradoJAThe limbusHoganMJHistology of the Human Eye: An Atlas and TextbookPhiladelphia, PAWB Saunders1971
   Google Scholar
• GregoryJKFosterCSPeripheral ulcerative keratitis in the collagen vascular diseasesInt Ophthalmol Clin19963621308778066
   PubMedGoogle Scholar
• ShiueyYFosterCSPeripheral ulcerative keratitis and collagen vascular diseaseInt Ophthalmol Clin19983821329532470
   PubMedGoogle Scholar
• GottschJDLiuSHStarkWJMooren’s ulcer and evidence of stromal graft rejection after penetrating keratoplastyAm J Ophthalmol19921134124171558115
   PubMed Web of Science ®Google Scholar
• MondinoBJExperimental aspects and models of peripheral corneal diseaseInt Ophthalmol Clin1986265143804635
   PubMedGoogle Scholar
• BrownSIMondinoBJRabinBSAutoimmune phenomenon in Mooren’s ulcerAm J Ophthalmol197682835840793402
   PubMed Web of Science ®Google Scholar
• KafkalaCChoiJZafirakisPMooren ulcer: an immunopathologic studyCornea20062566767317077658
   PubMed Web of Science ®Google Scholar
• FosterCSKenyonKRGreinerJThe immunopathology of Mooren’s ulcerAm J Ophthalmol197988149159382859
   PubMed Web of Science ®Google Scholar
• GottschJDLiuSHMinkovitzJBGoodmanDFSrinivasanMStarkWJAutoimmunity to a cornea associated stromal antigen in patients with Mooren’s ulcerInvest Ophthalmol Vis Sci199536154115477601634
   PubMed Web of Science ®Google Scholar
• ViraschVVBrasingtonRDLubniewskiAJCorneal disease in rheumatoid arthritisKrachmerJHMannisMJHollandEJCornea: Fundamentals, Diagnostic, Management3rd edSt Louis, MOElsevier2011
   Google Scholar
• Sainz de la MazaMJabburNSFosterCSSeverity of scleritis and episcleritisOphthalmology19941013893968115160
   PubMed Web of Science ®Google Scholar
• Sainz de la MazaMMolinaNGonzalesLADoctorPPTauberJFosterCSClinical characteristics of a large cohort of patients with scleritis and episcleritisOphthalmology2012119435021963265
   PubMed Web of Science ®Google Scholar
• KeenanDJMandelMRMargolisTPPeripheral ulcerative keratitis associated with vasculitis manifesting asymetrically as Fuchs superficial marginal keratitis and Terrien’s marginal dejenerationCornea20113082582721150425
   PubMed Web of Science ®Google Scholar
• AustinPBrownSIInflammatory Terrien’s marginal corneal diseaseAm J Ophthalmol1981921891927270631
   PubMed Web of Science ®Google Scholar
• SrinivasanMZegansMEZelefskyJRClinical characteristics of Mooren’s ulcer in South IndiaBr J Ophthalmol20079157057517035269
   PubMed Web of Science ®Google Scholar
• GargPSangwanVSMooren’s ulcerKrachmerJHMannisMJHollandEJCornea: Fundamentals, Diagnostic, Management3rd edSt Louis, MOElsevier2011
   Google Scholar
• TarabishyABSchulteMPapaliodisGNHoffmanGSWegener’s granulomatosis: clinical manifestations, differential diagnosis, and management of ocular and systemic diseaseSurv Ophthalmol201055430444
   Web of Science ®Google Scholar
• SoukiasianSHFosterCSNilesJLRaizmanMBDiagnostic value of anti-neutrophil cytoplasmic antibodies in scleritis associated with Wegener’s granulomatosisOphthalmology1992991251321741124
   PubMed Web of Science ®Google Scholar
• Sainz de la MazaMFosterCSJabburNSBaltatzisSOcular characteristics and disease associations in scleritis-associated peripheral keratopathyArch Ophthalmol2002120151911786052
   PubMedGoogle Scholar
• PerryHDGolubLMSystemic tetracyclines in the treatment of non-infected corneal ulcers: a case report and proposed new mechanism of actionAnn Ophthalmol1985177427444091374
   PubMedGoogle Scholar
• GolubLMRamamurthyNSMcNamaraTFGreenwaldRARifkinBRTetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugsCrit Rev Oral Biol Med199122973211654139
   PubMedGoogle Scholar
• RalphRATetracyclines and the treatment of corneal stromal ulceration: a reviewCornea20001927427710832682
   PubMed Web of Science ®Google Scholar
• JabsDARosenbaumJTFosterCSGuidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panelAm J Ophthalmol200013049251311024423
   PubMed Web of Science ®Google Scholar
• SquirrelDMWinfieldJAmosRSPeripheral ulcerative keratitis ‘corneal melt’ and rheumatoid arthritis: a case seriesRheumatology1999381245124810587553
   PubMed Web of Science ®Google Scholar
• GalorAJabsDALederHAComparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammationOphthalmology20081151826183218579209
   PubMed Web of Science ®Google Scholar
• ThorneJEJabsDAQaziFANguyenQDKempenJHDunnJPMycophenolate mofetil therapy for inflammatory eye diseaseOphthalmology20051121472147716061096
   PubMed Web of Science ®Google Scholar
• SobrinLChristenWFosterCSMycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitisOphthalmology20081151416142118221998
   PubMed Web of Science ®Google Scholar
• RobertsonSMLangLSLeflunomide: inhibition of S-antigen induced autoimmune uveitis in Lewis ratsAgents Actions1994421671727879705
   PubMedGoogle Scholar
• MessmerEFosterSDestructive corneal and scleral disease associated with rheumatoid arthritis: medical and surgical managementCornea1995144084177671613
   PubMed Web of Science ®Google Scholar
• McCarthyJMDubordPJChalmersAKassenBORangnoKKCyclosporin A for the treatment of necrotising scleritis and corneal melting in patients with rheumatoid arthritisJ Rheumatol199219135813611433000
   PubMed Web of Science ®Google Scholar
• Diaz-ValleDBenitez del CastilloJMSayaguesOSayaguésOBañaresAGarcía-SánchezJImmunological and clinical evaluation of postsurgical necrotising sclerocorneal ulcerationCornea1998173713759676907
   PubMed Web of Science ®Google Scholar
• SfikakisPPTheodossiadisPGKatsiariCGKaklamanisPMarkomichelakisNNEffect of infliximab on sight-threatening panuveitis in Behcet’s diseaseLancet200135829529611498218
   PubMed Web of Science ®Google Scholar
• SmithJRLevinsonRDHollandGNDifferential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic diseaseArthritis Care Res200145252257
   Web of Science ®Google Scholar
• OhYJKimMKWeeWRInfliximab for progressive peripheral ulcerative keratitis in a patient with juvenile rheumatoid arthiritisJpn J Ophthalmol201155707121331698
   PubMed Web of Science ®Google Scholar
• PhamMChowCCBadawiDTuEYUse of infliximab in the treatment of peripheral ulcerative keratitis in Crohn’s diseaseAm J Ophthalmol201115218318821652024
   PubMed Web of Science ®Google Scholar
• ThomasJPflugfelderSTherapy of progressive rheumatoid arthritis-associated corneal ulceration with infliximabCornea20052474274416015096
   PubMed Web of Science ®Google Scholar
• Tugal-TutkunIAyranciOKasapcopurOKirNRetrospective analysis of children with uveitis treated with infliximabJ AAPOS20081261161318930672
   PubMed Web of Science ®Google Scholar
• MurphyCCAyliffeWHBoothAMakanjuolaDAndrewsPAJayneDTumor necrosis factor a blockade with infliximab for refractory uveitis and scleritisOphthalmology200411135235615019389
   PubMed Web of Science ®Google Scholar
• GoffBLVabresBCochereauIEye loss by exogenous endophthalmitis following anti-tumor necrosis factor therapy: a report of 4 casesJ Rheumatol20093622022203
   Web of Science ®Google Scholar
• BongartzTSuttonAJSweetingMJBuchanIMattesonELMontoriVAnti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies. Systematic review and meta-analysis of rare harmful effects in randomized controlled trialsJAMA20062952275228516705109
   PubMed Web of Science ®Google Scholar
• ChungESPackerMLoKHRandomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure. Results of the anti-TNF therapy against congestive heart failure (ATTACH) trialCirculation20031073133314012796126
   PubMed Web of Science ®Google Scholar
• PuliSRBenageDDRetinal vein thrombosis after infliximab (Remicade) treatment for Crohn’s diseaseAm J Gastroenterol20039893994012738486
   PubMed Web of Science ®Google Scholar
• TheodossiadisPGMarkomichelakisNNSfikakisPPTumor necrosis factor antagonists. Preliminary evidence for an emerging approach in the treatment of ocular inflammationRetina20072739941317420690
   PubMed Web of Science ®Google Scholar
• Hernandez-IllasMTozmanEFulcherSRecombinant human tumor necrosis factor receptor Fc fusion protein (Etanercept): experience as a therapy for sight-threatening scleritis and sterile corneal ulcerationEye Contact Lens2004302514722460
   PubMedGoogle Scholar
• ManeoANaorJLeeHMHunterWSRootmanDSThree decades of corneal transplantation: indications and patient characteristicsCornea20001971110632000
   PubMed Web of Science ®Google Scholar
• ShimmuraSShimazakiJOhashiYTsubotaKAntiinflammatory effects of amniotic membrane transplantation in ocular surface disordersCornea20012040841311333331
   PubMed Web of Science ®Google Scholar
• HoulihanJMBiroPAHarperHMThe human anion is a site of MHC class Ib expression: evidence for the expression of HLA-E and HLA-GJ Immunol1995154566556747751618
   PubMed Web of Science ®Google Scholar
• GriffithTSBrunnerTFletcherSMGreenDRFergusonTAFas ligand-induced apoptosis as a mechanism of immune privilegeScience1995270118911927502042
   PubMed Web of Science ®Google Scholar
• McGheeNJPatelFPatelDVMooren’s ulcer and amniotic membrane transplant: a simple surgical solution?Clin Experiment Ophthalmol20113938338521749593
   PubMed Web of Science ®Google Scholar